{'fraction_non_alphanumeric': 0.016845329249617153, 'fraction_numerical': 0.02450229709035222, 'mean_word_length': 5.668367346938775, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Silica capsules enclosing P123 triblock copolymer micelles for flurbiprofen storage and release.

Flurbiprofen was incorporated in 200-400 nm silica capsules filled with Pluronic P123 polyethylene oxide-polypropylene oxide-polyethylene oxide triblock copolymer. The assembly process of the capsules and the molecular organization of drug molecule, surfactant and silica were investigated using SAXS, TGA, SEM, DLS, DSC, 13C single-pulse, CPMAS and 1H-1H two-dimensional NMR. Flurbiprofen molecules are molecularly dispersed inside polypropylene cores of P123 surfactant micelles occluded in a 20-30 nm thick silica shell. Flurbiprofen molecules in polypropylene cores of P123 micelles exhibit high mobility and are easily released after introduction in simulated gastrointestinal fluid and the solubility limit is reached within minutes. Release rates are favored at high pH due to acid dissociation of the carboxylic acid group of the flurbiprofen molecule. The molecular environment of flurbiprofen in these P123 filled silica capsules is different from ordered mesoporous silica materials synthesized using P123 as sacrificial template having the drug molecules adsorbed on the silica surface of pore walls. These findings uncover a new concept of storage and release of hydrophobic bioactive molecules.